Search results
FDA grants EUA for Watmind USA’s SpeedySwab Covid + FLU A&B self-test
Medical Device Network via Yahoo Finance· 2 days agoWatmind USA has been granted Emergency Use Authorization (EUA) by the US Food and Drug...
Watmind USA™ Receives FDA Emergency Use Authorization for SpeedySwab™ 15-Minute At-Home 3-in-1...
The Tomahawk· 5 days agoWatmind USA™, a leader in providing health diagnostic testing solutions, proudly announces that it...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations
QIAGEN (QGEN) Develops Test for Research and CDx Application
Zacks via Yahoo Finance· 5 days agoQIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid...
Get Your Free 2024 Mpox Vaccine, Say San Francisco Health Officials | KQED
KQED· 6 days agoSFDPH said that previous mpox outbreaks have predominantly affected communities of gay and bisexual...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 5 days agoThis immunobridging approach is designed to streamline the process for potential emergency use ...
Ocugen stock price analysis: good progress but a risky pattern forms | Invezz
Invezz· 7 days agoOcugen (NASDAQ: OCGN) stock price is doing well this year as investors focus on its ongoing drug...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 5 days agoInvivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 17 hours agoCrossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations, announces the successful closing of its rights offering ...